Leonard Dunn
Pulmonary Disease · Dunedin, FLNPI 1134127376
Payments from drug & device makers
Across 952 payments — averaging $7969.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$1.7M
- AstraZeneca$944K
- Verona Pharma, Inc.$939K
- AbbVie$749K
- Regeneron$661K
- Boehringer Ingelheim$631K
- plus $1.9M from 19 others
Across 7 payments — averaging $3153.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$22K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 52 | $1,749,564 |
| AstraZeneca | 22 | $943,675 |
| Verona Pharma, Inc. | 30 | $939,420 |
| AbbVie(2 entities) | 244 | $749,432 |
| Regeneron | 52 | $660,533 |
| Boehringer Ingelheim | 25 | $631,482 |
| Sanofi US Services Inc. | 72 | $351,312 |
| Gilead | 33 | $303,487 |
| Mylan Specialty L.p. | 22 | $263,680 |
| UCB SA | 28 | $225,268 |
| Sunovion Pharmaceuticals Inc. | 122 | $104,649 |
| Novo Nordisk AS | 28 | $90,624 |
| Endo Pharmaceuticals Inc. | 21 | $79,537 |
| Novartis | 5 | $71,163 |
| Bristol Myers Squibb | 11 | $69,404 |
| GSK | 21 | $69,350 |
| Astellas Pharma Inc | 12 | $55,280 |
| Teva Pharmaceuticals USA, Inc. | 12 | $54,214 |
| Noven Pharmaceuticals, Inc. | 25 | $50,731 |
| Biogen | 2 | $37,367 |
| Galderma Laboratories, L.p. | 9 | $36,512 |
| Genentech, Inc. | 2 | $23,245 |
| Boehringer Ingelheim International GmbH | 96 | $17,657 |
| Sumitomo Pharma America, Inc. | 5 | $9,224 |
| Vapotherm Inc | 1 | $19 |
How this compares
$7,586,830 in reported general payments places this provider in the 95th percentile of 953 pulmonary disease providers in Florida.
Other pulmonary disease in Dunedin
- James KrainsonMiami$11.7M
- Jose DiazLeesburg$11.2M
- Carlos MartinezHomestead$9.2M
- Francis AverillClearwater$6.3M
- Charles BurgerJacksonville$5.6M
- Daniel LorchBrandon$5.5M
- Lourdes BoschMiami$4.2M
- Raj KarunakaraOcala$4M
- Neal WarshoffLoxahatchee$3.6M
- Manuel SuarezMiami$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.